MedPath

eurofeedback a possible effective intervention for youth with AD(H)D and comorbid severe behavioral problems.

Completed
Conditions
ADHD
Attention Deficit Hyperactivity Disorder
10009841
Registration Number
NL-OMON31819
Lead Sponsor
GGZ Eindhoven (Eindhoven)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
28
Inclusion Criteria

* A positive screen on the Screeninglist ADHD (Kooij, 2002)
* IQ>80

Exclusion Criteria

* IQ<80
* suffer or have suffered from a medical condition that causes attention problems or hyperactivity (for example: anaemia, organic brain damage, low blood sugar levels)
* instable EEG pattern, determined with QEEG assessment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The feasibility and the clinical relevance are investigated with different<br /><br>study parameters. For the feasibility the number of the followed<br /><br>neurofeedbacktraining are registered and the attitude towards the training.<br /><br>For the clinical relevance of the neurofeedbacktraining for youth with AD(H)D<br /><br>and severe behavioural problems a QEEG assessment is conducted before and after<br /><br>the neurofeedbacktraining. Secondly using neuropsychological test the<br /><br>dysfuntioning related to the ADHD symptoms are described on four measurement<br /><br>moments.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p> __</p><br>
© Copyright 2025. All Rights Reserved by MedPath